신정임

전체 71건 중 11번부터 20번까지의 결과를 표시합니다.

2018

Article

Optimized Gemcitabine Therapy in Combination with E7 Peptide Immunization Elicits Tumor Cure by Preventing Ag-Specific CTL Inhibition in Animals with Large Established Tumors

Article

Purification and characterization of monoclonal IgG antibodies recognizing ebola virus glycoprotein

2017

Conference

Preferential production of IgG-secreting hybridomas by priming with DNA vaccines encoding Ebola virus glycoprotein with protein boosting: evaluation of IgGs for their properties

Conference

A timely combination of gemcitabine with human papillomavirus E7 peptide-based vaccines containing CpG-ODN and anti-4-1BB Abs enhances tumor eradication without tumor recurrence in a therapeutic TC-1

Conference

Proteasome degradation is associated with the loss of tumor cell’s antigenicity for immune evasion in a HER2-expressing tumor model

Article

Therapeutic Tumor Control of HER2 DNA Vaccines Is Achieved by an Alteration of Tumor Cells and Tumor Microenvironment by Gemcitabine and Anti-Gr-1 Ab Treatment in a HER2-Expressing Tumor Model

Article

Tumor regression is mediated via the induction of HER263-71-specific CD8+CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control

Article

Preferential production of IgM-secreting hybridomas by immunization with DNA vaccines coding for Ebola virus glycoprotein: Use of protein boosting for IgG-secreting hybridoma production

2016

Article

Gene therapy using plasmid DNA-encoded anti-HER2 antibody for cancers that overexpress HER2

Conference

Immune selection pressure allows tumor cells to post-transcriptionally inhibit antigen expression for immune evasion in a HER2-expressing tumor model

상세 보기

신정임

연구분야

자료유형

발행연도

키워드

언어

Optimized Gemcitabine Therapy in Combination with E7 Peptide Immunization Elicits Tumor Cure by Preventing Ag-Specific CTL Inhibition in Animals with Large Established Tumors

Purification and characterization of monoclonal IgG antibodies recognizing ebola virus glycoprotein

Preferential production of IgG-secreting hybridomas by priming with DNA vaccines encoding Ebola virus glycoprotein with protein boosting: evaluation of IgGs for their properties

A timely combination of gemcitabine with human papillomavirus E7 peptide-based vaccines containing CpG-ODN and anti-4-1BB Abs enhances tumor eradication without tumor recurrence in a therapeutic TC-1

Proteasome degradation is associated with the loss of tumor cell’s antigenicity for immune evasion in a HER2-expressing tumor model

Therapeutic Tumor Control of HER2 DNA Vaccines Is Achieved by an Alteration of Tumor Cells and Tumor Microenvironment by Gemcitabine and Anti-Gr-1 Ab Treatment in a HER2-Expressing Tumor Model

Tumor regression is mediated via the induction of HER263-71-specific CD8+CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control

Preferential production of IgM-secreting hybridomas by immunization with DNA vaccines coding for Ebola virus glycoprotein: Use of protein boosting for IgG-secreting hybridoma production

Gene therapy using plasmid DNA-encoded anti-HER2 antibody for cancers that overexpress HER2

Immune selection pressure allows tumor cells to post-transcriptionally inhibit antigen expression for immune evasion in a HER2-expressing tumor model